Carregant...
Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients
Background: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. Methods: Thus, w...
Guardat en:
| Publicat a: | medRxiv |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cold Spring Harbor Laboratory
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274247/ https://ncbi.nlm.nih.gov/pubmed/32511566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.12.20099879 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|